143 related articles for article (PubMed ID: 20656892)
21. Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.
Umar S; Rabinovitch M; Eghbali M
Am J Respir Crit Care Med; 2012 Jul; 186(2):125-31. PubMed ID: 22561960
[TBL] [Abstract][Full Text] [Related]
22. The influence of gender on the development of pulmonary arterial hypertension.
Dempsie Y; MacLean MR
Exp Physiol; 2013 Aug; 98(8):1257-61. PubMed ID: 23625955
[TBL] [Abstract][Full Text] [Related]
23. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.
Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y
Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159
[TBL] [Abstract][Full Text] [Related]
24. Current insights on the pathogenesis of pulmonary arterial hypertension.
Perros F; Dorfmüller P; Humbert M
Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
[TBL] [Abstract][Full Text] [Related]
25. 4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.
Carroll-Turpin M; Hebert V; Chotibut T; Wensler H; Krentzel D; Varner KJ; Burn BR; Chen YF; Abreo F; Dugas TR
Toxicol Sci; 2015 Sep; 147(1):235-45. PubMed ID: 26116029
[TBL] [Abstract][Full Text] [Related]
26. Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.
Wilson JL; Warburton R; Taylor L; Toksoz D; Hill N; Polgar P
PLoS One; 2018; 13(4):e0195780. PubMed ID: 29649319
[TBL] [Abstract][Full Text] [Related]
27. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox.
Voelkel NF; Gomez-Arroyo J
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):474-84. PubMed ID: 24932885
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
Yan D; Li G; Zhang Y; Liu Y
Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
[No Abstract] [Full Text] [Related]
31. 17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension.
Liu A; Tian L; Golob M; Eickhoff JC; Boston M; Chesler NC
Hypertension; 2015 Nov; 66(5):1082-8. PubMed ID: 26418020
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
[TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension.
Reynolds AM; Xia W; Holmes MD; Hodge SJ; Danilov S; Curiel DT; Morrell NW; Reynolds PN
Am J Physiol Lung Cell Mol Physiol; 2007 May; 292(5):L1182-92. PubMed ID: 17277049
[TBL] [Abstract][Full Text] [Related]
34. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary Arterial Hypertension and the Sex Hormone Paradox.
Foderaro A; Ventetuolo CE
Curr Hypertens Rep; 2016 Nov; 18(11):84. PubMed ID: 27832457
[TBL] [Abstract][Full Text] [Related]
36. The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone.
Lahm T; Crisostomo PR; Markel TA; Wang M; Weil BR; Novotny NM; Meldrum DR
Crit Care Med; 2008 Jul; 36(7):2174-83. PubMed ID: 18552699
[TBL] [Abstract][Full Text] [Related]
37. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
38. Connexin-mediated regulation of the pulmonary vasculature.
Dempsie Y; Martin P; Upton PD
Biochem Soc Trans; 2015 Jun; 43(3):524-9. PubMed ID: 26009202
[TBL] [Abstract][Full Text] [Related]
39. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
40. Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension.
Tofovic SP; Jackson EK
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
